According to a new study, patients with psoriasis have a 20% greater risk of organ-based comorbidities when compared with the general population.
Study shows dietary changes can improve AD symptoms
According to a new study, dietary changes may improve symptoms in patients with mild or moderate atopic dermatitis (AD) when used in conjunction with regular treatment. However, the authors note there are risks associated with elimination diets that should be discussed.
Researchers identify molecular factors in melanoma gene mutation
A new study has revealed molecular information of a gene mutation linked to between 15 and 20% of all melanomas that may lead to new treatments and prevention strategies.
Vitamin D supplementation during pregnancy may lower risk of AD in infants, study shows
According to a new study, taking vitamin D supplements during pregnancy may reduce the likelihood of infants developing atopic dermatitis (AD) in their first year of life.
Rosacea patients have increased likelihood of sensorineural hearing loss, according to study
Rosacea patients are more likely to experience high frequency sensorineural hearing loss according to a recent study.
Researchers use mussel adhesive protein for scarless skin grafts
Researchers have developed a bioadhesive based on mussel adhesive protein to help wounds heal with minimal scarring. The adhesive assists skin transplantation in healing the skin without the use of sutures.
Psoriasis patients value skin clearance, symptom control as most important treatment outcomes
Patients with psoriasis value skin clearance and symptom control as the most important treatment outcomes, according to a new study.
Thirdhand smoke exposure can cause skin damage
According to a new study concentrations of nicotine that settle on surfaces, also called thirdhand smoke (THS), as well as electronic cigarette spills can damage the skin.
Study suggests prevalence of keratosis pilaris is low in AD patients
According to a new study, the prevalence of keratosis pilaris (KP) is low in patients with atopic dermatitis (AD).
New study shows tildrakizumab may be effective for difficult-to-treat areas in psoriasis
According to a new study, tildrakizumab treatment for psoriasis showed a significant improvement when used for difficult-to-treat areas such as the scalp, nail, palms and genitals.
HealthMinute.TV 